RESUMO
The objective of the current study was to investigate the metabolism of cytochrome P450 (CYP) probe substrates in male Sprague Dawley rat liver microsomes and to determine their substrate specificities. Time and microsomal protein concentrations were varied to determine the linear conditions for each reaction. Appropriate substrate concentrations were chosen to determine the apparent K(m) and V(max) for 17 different reactions under initial rate conditions of protein and reaction time. All reactions appeared to follow Michaelis-Menten kinetics. Subsequently, each substrate was incubated at one to two times K(m) with each of 14 baculovirus cDNA-expressed rat CYP enzymes to determine the specificity of the reaction monitored. Of the 14 enzymes tested, seven were seen as the major rat CYP enzymes responsible for the majority of the substrate metabolism tested. Testosterone 2alpha- and 16alpha-hydroxylation reactions were conducted primarily by CYP2C11, and midazolam 4-hydroxylation and triazolam 1'-hydroxylation were preferentially catalyzed by CYP3A1/2, but specificity was otherwise generally poor. The results presented herein clearly indicate that care must be taken in interpretation of metabolism results obtained in rats using standard probe substrates, especially in extrapolation of those results to humans.
Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Sondas Moleculares/metabolismo , Animais , Catálise , Cromatografia Líquida de Alta Pressão , DNA Complementar , Humanos , Cinética , Masculino , Microssomos Hepáticos/enzimologia , Ratos , Ratos Sprague-Dawley , Especificidade por SubstratoRESUMO
Three highly A2a-selective adenosine agonists were examined for their effects on blood pressure during chronic administration in conscious spontaneously hypertensive rats. Sodium 4-[2-[[6-amino-9-(N-ethyl-beta-D-ribofuranuronamidosyl)-9H-purin-2 -yl] amino]ethyl]benzenepropionate (CGS 21680C) 2-[(2-cyclohexyl-ethyl)amino]adenosine (CGS 22492) and 2-[[2-(1-cyclohexen-1-yl)ethyl]amino]adenosine (CGS 22989) were administered at a rate of 0.25 and 0.5 micrograms/kg/min i.v. for 2 weeks using osmotic minipumps. Significant systolic blood pressure reductions were seen in the A2a agonist-treated groups compared to vehicle-treated (50% dimethyl sulfoxide) animals. Maximum effects occurred on days 1 and 2 in the treated animals. However, the antihypertensive effect diminished with time such that no differences between treatments were seen at 2 weeks. In contrast, a sustained antihypertensive effect was evident with benazeprilat (an angiotensin converting enzyme inhibitor). Tolerance was associated with a decrease in Bmax values (375 +/- 22, 410 +/- 18 and 548 +/- 17 fmol/mg of protein in the CGS 21680C, CGS 22989- and vehicle-treated spontaneously hypertensive rats, respectively) without affecting the Kd value. In addition to a reduction in A2 receptor number, increased heart rates were seen on day 1 and 2 in both the CGS 21680C- and CGS 22989-treated animals and a mild stimulation of the renin angiotensin system occurred with CGS 21680C. In separate acute experiments using identical infusion rates, plasma concentrations of CGS 21680C were 157 +/- 41 ng/ml compared to 30.4 +/- 8.8 ng/ml after chronic administration.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Adenosina/análogos & derivados , Anti-Hipertensivos/administração & dosagem , Cicloexanos/farmacologia , Receptores Purinérgicos P1/efeitos dos fármacos , Adenosina/sangue , Adenosina/metabolismo , Adenosina/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Corpo Estriado/metabolismo , Cicloexanos/sangue , Relação Dose-Resposta a Droga , Tolerância a Medicamentos , Frequência Cardíaca/efeitos dos fármacos , Masculino , Fenetilaminas/sangue , Fenetilaminas/metabolismo , Fenetilaminas/farmacologia , Ratos , Ratos Endogâmicos SHR , Renina/sangue , Fatores de TempoRESUMO
CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5'-N- ethylcarboxamidoadenosine, I) is a highly A2-selective (A2/A1 = 140), high-affinity adenosine agonist. A method has been devised to extract the compound from biological matrices with automated solid-phase extraction using C18 bonded silica columns. This is followed by reversed-phase, paired-ion chromatography on a Supelco LC-18-S column with fluorescence detection. The limit of quantitation is 5 ng/ml, but 1 ng/ml (five times the signal-to-noise ratio) can readily be detected. Tritium-labeled compound was used to study the pharmacokinetics in rats. After an intravenous dose of 0.3 mg/kg, biphasic elimination kinetics were observed for parent I, characterized by half-lives of 1.8 min (distribution) and 15 min (elimination). The volume of distribution in the terminal phase (V beta) was low (0.27 l/kg) and plasma clearance was moderate (0.83 l/kg/h). Although the compound was rapidly absorbed (mean Tmax = 13 min), low concentrations (mean Cmax = 94 ng/ml) were observed after an oral dose of 3.0 mg/kg, and bioavailability was only approximately 1.4%. Radioactivity persisted in plasma longer than parent compound after either dose, but levels were too low for isolation and structure identification of drug-derived compounds.
Assuntos
Adenosina/análogos & derivados , Fenetilaminas/sangue , Receptores Purinérgicos/análise , Adenosina/sangue , Adenosina/isolamento & purificação , Adenosina/farmacocinética , Animais , Disponibilidade Biológica , Cromatografia Líquida de Alta Pressão/métodos , Masculino , Fenetilaminas/isolamento & purificação , Fenetilaminas/farmacocinética , Ratos , Ratos Endogâmicos , Receptores Purinérgicos/efeitos dos fármacos , Padrões de ReferênciaRESUMO
Although bleomycin is a known pulmonary toxin, results presented herein indicate its relative safety for treatment of trypanosomiasis. More than 4 times the curative dose in this acute model of infection does not induce significant alterations of lung hydroxyproline levels, which are known to directly correlate with histopathological criteria of pulmonary fibrosis.
Assuntos
Bleomicina/toxicidade , Pulmão/efeitos dos fármacos , Tripanossomíase Africana/tratamento farmacológico , Animais , Bleomicina/uso terapêutico , Hidroxiprolina/análise , Pulmão/análise , Camundongos , Fibrose Pulmonar/induzido quimicamente , Trypanosoma brucei bruceiRESUMO
Meclizine, used prophylactically for the prevention of motion sickness and vertigo, is presently available only in oral form. We report herein that, when given intranasally, meclizine dihydrochloride is absorbed in rats about half as effectively as when given intravenously, but about six times more effectively than after oral administration, as estimated by the area under the plasma concentration-time curve. The mean times to peak levels in plasma are about 8.5 min after an intranasal dose and 49.0 min after oral delivery. We extended these studies to a second species, the beagle dog, and achieved qualitatively similar results with a new formulation (Mecnazone; Nastech Pharmaceutical Co., Inc.). The fraction absorbed intranasally was about 0.89 that of an equivalent intravenous dose but about four times that of an equivalent oral administration. In these studies, the mean times to peak levels in plasma was 11.9 min after an intranasal dose and 70.0 min after an oral dose. Terminal elimination kinetics were the same for all routes within each species. Intranasal delivery of meclizine therefore appears to be superior to the oral route for the more rapid achievement of substantial levels in plasma at a reduced dose.
Assuntos
Meclizina/sangue , Administração Intranasal , Administração Oral , Animais , Cromatografia Líquida de Alta Pressão , Cães , Injeções Intravenosas , Cinética , Meclizina/administração & dosagem , Ratos , Especificidade da EspécieRESUMO
A rapid, linear gradient chromatographic technique for separating and quantifying copper(II)-chelated bleomycin congeners is described. This method is also capable of separating divalent from trivalent metal chelates; determining the purity of many chemically modified bleomycins; and assaying bleomycin hydrolase activity on complex mixtures. Quantification at 280 nm is sensitive to 50 pmol and is linear at least up to 10 nmol per injection.
Assuntos
Bleomicina/análise , Cisteína Endopeptidases , Animais , Quelantes/análise , Cromatografia Líquida de Alta Pressão/métodos , Cobre/análise , Glicosídeo Hidrolases/análise , Fígado/enzimologia , Camundongos , OxirreduçãoRESUMO
We have previously demonstrated that endotracheal administration of the terminal amines of several bleomycins, when administered as the free amines, produce pulmonary fibrosis of severity comparable to the intact drug. In the present report, bleomycin A2 and its sulfonium ion-containing terminal substituents, with and without the bithiazole rings, were administered to mice endotracheally. The incidence and severity of epithelial metaplasia was greater with the intact drug in comparison to the terminal substituents. In contrast, the terminal substituents and intact drug produced similar degrees of fibrosis. These results underscore the importance of the variable bleomycin terminal substituents in the pathogenesis of pulmonary fibrosis.
Assuntos
Bleomicina/farmacologia , Pulmão/efeitos dos fármacos , Fibrose Pulmonar/induzido quimicamente , Animais , Relação Dose-Resposta a Droga , Epitélio/patologia , Pulmão/patologia , Masculino , Metaplasia/induzido quimicamente , Camundongos , Camundongos Endogâmicos DBARESUMO
The loss of mechanical function in rat hearts subjected to either the calcium-paradox or global ischemia heart failure models was found to correlate with decreases in myocardial taurine levels. Therefore, the effect of taurine treatment was assessed in the two failure procedures. The presence of taurine protected against loss of mechanical function resulting from the calcium paradox and prevented both the large decline in sarcolemmal ATPase activities and the increase in sarcolemmal calcium binding normally associated with this model. Parallel studies on reperfused, taurine-untreated ischemic hearts showed only minor changes in these sarcolemmal functions. Taurine treatment normalized the slight increase in calcium binding associated with ischemia, but had no observable effect on recovery of mechanical function. Although taurine returns selected parameters of the sarcolemma toward normal in both models, it only improves mechanical function in the paradox model. This suggests that calcium paradox-induced heart failure is more closely associated with sarcolemmal dysfunction than ischemic heart failure.
Assuntos
Cálcio/metabolismo , Doença das Coronárias/metabolismo , Insuficiência Cardíaca/metabolismo , Miocárdio/metabolismo , Taurina/farmacologia , Adenosina Trifosfatases/metabolismo , Animais , Cálcio/farmacologia , Técnicas In Vitro , Masculino , Ratos , Sarcolema/enzimologia , Sarcolema/metabolismo , Taurina/metabolismoAssuntos
Cálcio/metabolismo , Furazolidona/toxicidade , Cardiopatias/veterinária , Doenças das Aves Domésticas/metabolismo , Taurina/metabolismo , Perus/metabolismo , Animais , Cardiopatias/induzido quimicamente , Cardiopatias/metabolismo , Miocárdio/metabolismo , Doenças das Aves Domésticas/induzido quimicamente , Sarcolema/metabolismoRESUMO
The role of taurine in maintaining calcium and potassium homeostasis in excitable tissues is discussed. These effects of taurine appear to be related to its interaction with a low affinity binding protein of the cell membrane. This conclusion is based on the observation that the sulfinic acid analog of taurine, hypotaurine, also interacts with this protein and mimics these actions of taurine, whereas two other analogs, beta-alanine and isethionic acid, have little affinity for the binding protein and fail to exhibit taurine-like activity. The possibility that a relationship exists between the low affinity protein and sarcolemmal calcium pools is considered.
Assuntos
Cálcio/metabolismo , Miocárdio/metabolismo , Taurina/fisiologia , Animais , Proteínas de Transporte/metabolismo , Cobaias , Homeostase , Proteínas de Membrana/metabolismo , Potássio/metabolismo , Ratos , Sarcolema/metabolismo , Suínos , Taurina/análogos & derivados , Taurina/farmacologiaRESUMO
The effect of taurine on calcium binding to isolated rat heart sarcolemmal membrane was examined. Taurine was observed to increase calcium binding to the low affinity sites in both high sodium-low potassium and low sodium-high potassium buffers. Taurine was also seen to antagonize the inhibition of calcium binding to the sarcolemma caused by both verapamil and lanthanum. Nevertheless, membrane structural changes due to taurine could not be detected using the spin label ESR probe 2N14. A possible regulatory role of taurine is discussed.